Longlight announced that it has received $1,380,000 in angel round of funding led by Yanghe Capital Holding Group Limited on October 25, 2022. The transaction included participation from Shenzhen YHLO Biotech Co., Ltd.
Shenzhen YHLO Biotech Co., Ltd.
Equities
688575
CNE100005204
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.54 CNY | -1.05% | +7.98% | +2.93% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.93% | 1.85B | |
+72.75% | 12.34B | |
-17.86% | 7.96B | |
+15.91% | 7.16B | |
+5.08% | 5.72B | |
+6.51% | 5.03B | |
+21.99% | 4.35B | |
-21.67% | 3.99B | |
-40.78% | 2.21B | |
+0.87% | 2.01B |
- Stock Market
- Equities
- 688575 Stock
- News Shenzhen YHLO Biotech Co., Ltd.
- Longlight announced that it has received $1.380000 million in funding from Shenzhen YHLO Biotech Co., Ltd., Yanghe Capital Holding Group Limited and other investors.